当前位置:产品中心 > 抗体 > Biosimilar抗体 > 免疫 > Anti-Integrin α4β7 hIgG1 Reference Antibody (Vedobio)
Anti-Integrin α4β7 hIgG1 Reference Antibody (Vedobio)
基本信息

产品编号:GM-87988MAB

产品名称:Anti-Integrin α4β7 hIgG1 Reference Antibody (Vedobio)

目录价:询价


产品配图.jpg


规格货号

GM-87988MAB-1mg / 1 mg

GM-87988MAB-5mg / 5 mg

GM-87988MAB-25mg / 5 mg * 5 vials

GM-87988MAB-50mg / 50 mg

GM-87988MAB-100mg / 50 mg * 2 vials

产品简介

Expression System      CHO

Aggregation                < 5% as determined by SEC-HPLC

Purity                           > 95% as determined by SDS-PAGE

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay

Sterility                        0.2 μm Filtered

Target                          Vedolizumab

Clone                               Ocrelizumab

Alternative Names         Lymphocyte Peyer’s patch adhesion molecule-1 (LPAM-1)

Source/Isotype           Monoclonal Human IgG1(KDEL), Kappa

Application                      /

Description                Vedolizumab is a selective monoclonal antibody targeting integrin α4β7. By blocking the interaction between integrin α4β7 and MadCAM-1, it reduces the accumulation of inflammatory lymphocytes in the intestinal mucosa, thereby suppressing intestinal inflammation while preserving systemic immune function.

Formulation                phosphate-buffered solution, pH 7.2-7.4.



数据展示

image.png

image.png


当前位置:产品中心 > 抗体 > Biosimilar抗体 > Anti-Integrin α4β7 hIgG1 Reference Antibody (Vedobio)

Anti-Integrin α4β7 hIgG1 Reference Antibody (Vedobio)
基本信息

产品编号:GM-87988MAB

产品名称:Anti-Integrin α4β7 hIgG1 Reference Antibody (Vedobio)

目录价:询价


产品配图.jpg


规格货号

GM-87988MAB-1mg / 1 mg

GM-87988MAB-5mg / 5 mg

GM-87988MAB-25mg / 5 mg * 5 vials

GM-87988MAB-50mg / 50 mg

GM-87988MAB-100mg / 50 mg * 2 vials

产品简介

Expression System      CHO

Aggregation                < 5% as determined by SEC-HPLC

Purity                           > 95% as determined by SDS-PAGE

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay

Sterility                        0.2 μm Filtered

Target                          Vedolizumab

Clone                               Ocrelizumab

Alternative Names         Lymphocyte Peyer’s patch adhesion molecule-1 (LPAM-1)

Source/Isotype           Monoclonal Human IgG1(KDEL), Kappa

Application                      /

Description                Vedolizumab is a selective monoclonal antibody targeting integrin α4β7. By blocking the interaction between integrin α4β7 and MadCAM-1, it reduces the accumulation of inflammatory lymphocytes in the intestinal mucosa, thereby suppressing intestinal inflammation while preserving systemic immune function.

Formulation                phosphate-buffered solution, pH 7.2-7.4.



数据展示

image.png

image.png


Tel: 400-627-9288
留言咨询
重置
提交
客服
微信
电话
留言
留言咨询
重置
提交